NCT03131492View on ClinicalTrials.gov

Early Dehiscence Markers in Ovarian Cancer Surgery

CompletedOBSERVATIONAL
Enrollment

92

Participants

Timeline

Start Date

March 1, 2017

Primary Completion Date

December 31, 2020

Study Completion Date

July 31, 2021

Conditions
Ovarian Neoplasms MalignantAnastomotic Leak
Interventions
DIAGNOSTIC_TEST

Blood test

C-reactive protein and PCT measured preoperatively, and on the second, fourth and sixth postoperative days.

Trial Locations (1)

08035

Hospital Universitari de la Vall d'Hebron, Barcelona

All Listed Sponsors
lead

Hospital Universitari Vall d'Hebron Research Institute

OTHER

NCT03131492 - Early Dehiscence Markers in Ovarian Cancer Surgery | Biotech Hunter | Biotech Hunter